These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23521092)

  • 21. Replacing the factor VIII C1 domain with a second C2 domain reduces factor VIII stability and affinity for factor IXa.
    Wakabayashi H; Fay PJ
    J Biol Chem; 2013 Oct; 288(43):31289-97. PubMed ID: 24030831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of factor VIII by thrombin increases its affinity for binding to synthetic phospholipid membranes and activated platelets.
    Saenko EL; Scandella D; Yakhyaev AV; Greco NJ
    J Biol Chem; 1998 Oct; 273(43):27918-26. PubMed ID: 9774404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cofactor activities of factor VIIIa and A2 subunit following cleavage of A1 subunit at Arg336.
    Koszelak Rosenblum ME; Schmidt K; Freas J; Mastri M; Fay PJ
    J Biol Chem; 2002 Apr; 277(14):11664-9. PubMed ID: 11799130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mild hemophilia A caused by increased rate of factor VIII A2 subunit dissociation: evidence for nonproteolytic inactivation of factor VIIIa in vivo.
    Pipe SW; Eickhorst AN; McKinley SH; Saenko EL; Kaufman RJ
    Blood; 1999 Jan; 93(1):176-83. PubMed ID: 9864159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factor VIII light chain contains a binding site for factor X that contributes to the catalytic efficiency of factor Xase.
    Takeyama M; Wakabayashi H; Fay PJ
    Biochemistry; 2012 Jan; 51(3):820-8. PubMed ID: 22224589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A1 subunit-mediated regulation of thrombin-activated factor VIII A2 subunit dissociation.
    Parker ET; Doering CB; Lollar P
    J Biol Chem; 2006 May; 281(20):13922-30. PubMed ID: 16513639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hydrogen-Deuterium Exchange Mass Spectrometry Identifies Activated Factor IX-Induced molecular Changes in Activated Factor VIII.
    van Galen J; Freato N; Przeradzka MA; Ebberink EHTM; Boon-Spijker M; van der Zwaan C; van den Biggelaar M; Meijer AB
    Thromb Haemost; 2021 May; 121(5):594-602. PubMed ID: 33302303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activated protein C-catalyzed proteolysis of factor VIIIa alters its interactions within factor Xase.
    Regan LM; O'Brien LM; Beattie TL; Sudhakar K; Walker FJ; Fay PJ
    J Biol Chem; 1996 Feb; 271(8):3982-7. PubMed ID: 8626729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localization of a factor X interactive site in the A1 subunit of factor VIIIa.
    Lapan KA; Fay PJ
    J Biol Chem; 1997 Jan; 272(4):2082-8. PubMed ID: 8999906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The active site of factor IXa is located far above the membrane surface and its conformation is altered upon association with factor VIIIa. A fluorescence study.
    Mutucumarana VP; Duffy EJ; Lollar P; Johnson AE
    J Biol Chem; 1992 Aug; 267(24):17012-21. PubMed ID: 1512240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Residues surrounding Arg336 and Arg562 contribute to the disparate rates of proteolysis of factor VIIIa catalyzed by activated protein C.
    Varfaj F; Wakabayashi H; Fay PJ
    J Biol Chem; 2007 Jul; 282(28):20264-72. PubMed ID: 17519239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced factor VIIIa stability of A2 domain interface variants results from an increased apparent affinity for the A2 subunit. Results from an increased apparent affinity for the A2 subunit.
    Monaghan M; Wakabayashi H; Griffiths A; Wintermute J; Fay PJ
    Thromb Haemost; 2014 Sep; 112(3):495-502. PubMed ID: 24899227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C2 domain of protein kinase C alpha: elucidation of the membrane docking surface by site-directed fluorescence and spin labeling.
    Kohout SC; Corbalán-García S; Gómez-Fernández JC; Falke JJ
    Biochemistry; 2003 Feb; 42(5):1254-65. PubMed ID: 12564928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of residues contributing to A2 domain-dependent structural stability in factor VIII and factor VIIIa.
    Wakabayashi H; Fay PJ
    J Biol Chem; 2008 Apr; 283(17):11645-51. PubMed ID: 18299331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered interactions between the A1 and A2 subunits of factor VIIIa following cleavage of A1 subunit by factor Xa.
    Nogami K; Wakabayashi H; Schmidt K; Fay PJ
    J Biol Chem; 2003 Jan; 278(3):1634-41. PubMed ID: 12426309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sites in the A2 subunit involved in the interfactor VIIIa interaction.
    Koszelak ME; Huggins CF; Fay PJ
    J Biol Chem; 2000 Sep; 275(35):27137-44. PubMed ID: 10831590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of P1 residues Arg336 and Arg562 in the activated-Protein-C-catalysed inactivation of Factor VIIIa.
    Varfaj F; Neuberg J; Jenkins PV; Wakabayashi H; Fay PJ
    Biochem J; 2006 Jun; 396(2):355-62. PubMed ID: 16503879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of hydrophobic mutations on the binding affinity and stability of blood coagulation factor VIIIa: a computational molecular dynamics and free-energy analysis.
    Venkateswarlu D
    Biochem Biophys Res Commun; 2014 Jul; 450(1):735-40. PubMed ID: 24952158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural investigation of zymogenic and activated forms of human blood coagulation factor VIII: a computational molecular dynamics study.
    Venkateswarlu D
    BMC Struct Biol; 2010 Feb; 10():7. PubMed ID: 20184747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding of factor VIIIa and factor VIII to factor IXa on phospholipid vesicles.
    Duffy EJ; Parker ET; Mutucumarana VP; Johnson AE; Lollar P
    J Biol Chem; 1992 Aug; 267(24):17006-11. PubMed ID: 1512239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.